CORCEPT THERAPEUTICS INC CORT

Latest FY: 2025 Healthcare Biotechnology
Market Price $114.85
Market Cap $12.34B
P/E Ratio 140.06
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑12.8% YoY
$761.41M
3-Yr CAGR: 23.7%
Net Income ↓-29.4% YoY
$99.65M
Net Margin: 13.1%
Free Cash Flow ↓-27.6% YoY
$141.78M
FCF Yield: 1.15%
EPS (Diluted) ↓-33.3% YoY
$0.82
Basic: $0.95
Return on Equity Efficiency
15.4%
ROA: 11.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CORT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $81.3M $79.3M $8.1M $0.07 0.00% $18.4M $18.2M
FY 2017 $159.2M +95.8% $155.6M $129.1M +1,486.3% $1.04 +1,385.7% 0.00% $60.9M $60.5M +232.6%
FY 2018 $251.2M +57.8% $246.0M $75.4M -41.6% $0.60 -42.3% 0.00% $115.7M $115.4M +90.6%
FY 2019 $306.5M +22.0% $301.0M $94.2M +24.9% $0.77 +28.3% 0.00% $136.1M $135.0M +17.0%
FY 2020 $353.9M +15.5% $348.3M $106.0M +12.6% $0.85 +10.4% 0.00% $152.0M $150.7M +11.6%
FY 2021 $366.0M +3.4% $360.7M $112.5M +6.1% $0.89 +4.7% 0.00% $167.9M $167.4M +11.1%
FY 2022 $401.9M +9.8% $396.5M $101.4M -9.9% $0.87 -2.2% 0.00% $120.3M $119.9M -28.4%
FY 2023 $482.4M +20.0% $475.9M $106.1M +4.7% $0.94 +8.0% 0.00% $127.0M $126.9M +5.8%
FY 2024 $675.0M +39.9% $664.2M $141.2M +33.0% $1.23 +30.9% 0.00% $198.1M $195.9M +54.4%
FY 2025 $761.4M +12.8% $748.4M $99.7M -29.4% $0.82 -33.3% 0.00% $142.0M $141.8M -27.6%
$

Valuation

Market Price $114.85
Market Cap $12.34B
Enterprise Value $12.22B
P/E Ratio 140.06
P/B Ratio 19.03
FCF Yield 1.15%
Dividend Yield N/A
Shares Outstanding 107,351,600
%

Profitability & Margins

Gross Margin 98.30%
Operating Margin 5.88%
Net Margin 13.09%
Return on Equity (ROE) 15.38%
Return on Assets (ROA) 11.91%
Asset Turnover 0.91x
Revenue 3-Yr CAGR 23.74%
🛡️

Financial Health & Liquidity

Current Ratio 2.92
Cash Ratio 0.73
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $120.50M
Total Debt N/A
Book Value / Share $6.03
💧

Cash Flow Efficiency

Operating Cash Flow $142.00M
Capital Expenditures (CapEx) $211.00K
Free Cash Flow $141.78M
OCF / Revenue 18.65%
FCF / Revenue 18.62%
FCF 3-Yr CAGR 5.74%
🏷️

Per Share Metrics

EPS (Diluted) $0.82
EPS (Basic) $0.95
Dividends / Share N/A
Book Value / Share $6.03
EPS YoY Growth -33.33%
🏛️

Balance Sheet (FY 2025)

Total Assets $836.65M
Total Liabilities $188.85M
Stockholders' Equity $647.80M
Current Assets $485.46M
Current Liabilities $166.09M